Clever Culture Systems AG - Product Pipeline Analysis, 2021 Update

Clever Culture Systems AG - Product Pipeline Analysis, 2021 Update

Summary

Clever Culture Systems AG (Clever Culture Systems) manufactures an in vitro diagnostic instrument to analyze agar culture plates. The company offers APAS (automated plate assessment system) Independence, a culture plate reading instrument that utilizes APAS imaging software and artificial intelligence algorithms to read, interpret and screen the presence of bacterial growth on microbiology culture plates. Its technology also helps in differentiating common colony morphologies and generate accurate microbiology test reports. Clever Culture Systems markets its product through distributors and partners in Australia, Europe and the US. The company is a joint venture between LBT Innovations Ltd and Hettich Holding Beteiligungs und Verwaltungs GmbH. Clever Culture Systems is headquartered in Bach, Schwyz, Switzerland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

• The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
• The report analyzes all pipeline products in development for the company Clever Culture Systems AG
• The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
• The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
• The report provides detailed description of products in development, technical specification and functions
• The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

• Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
• Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
• To formulate effective Research & Development strategies
• Develop market-entry and market expansion strategies
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
• Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note:Some sections may be missing if data is unavailable for the company

Companies Mentioned

Stratec SE
BMG Labtech GmbH
BioTek Instruments Inc
Analytik Jena AG